The Medical Affairs Function: Characteristics of Superior Organizational Structures

Market and regulatory pressures, competition and globalization are influencing how pharmaceutical companies are organizing their medical affairs department. Using the information in this 22 page document, companies can gain insight in how to overcome the obstacles that pharmaceutical companies face in designing such programs. The following practices describe how pharmaceutical, healthcare and biotech companies can organize their medical affairs departments.

Key Questions

• How are functional capabilities and therapeutic areas organized?
• To where do U.S. and global medical departments report—R&D, Medical Affairs, CEO or Marketing/Business Unit?
• How is the geographic span of responsibility allocated throughout the world?
• For what phases of lifecycle management is medical affairs responsible?
  

• Challenges for the Medical Affairs Function
• Medical Affairs Function: Mission, Roles and Responsibilities
• Geographic Span of Responsibility
• Product Lifecycle Span of Responsibility
• Functional Components and Structure
• Cross-Functional Interfaces Through Teams and Processes

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at [email protected] or call David Guinn at 919-767-9179 if you have any questions.